These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8184913)

  • 1. Role of ouabainlike compound in rats with reduced renal mass-saline hypertension.
    Yamada K; Goto A; Hui C; Yagi N; Nagoshi H; Sasabe M; Sugimoto T
    Am J Physiol; 1994 Apr; 266(4 Pt 2):H1357-62. PubMed ID: 8184913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of ouabainlike compound levels with hypertonic sodium chloride load in rat plasma and tissues.
    Yamada K; Goto A; Nagoshi H; Terano Y; Omata M
    Hypertension; 1997 Jul; 30(1 Pt 1):94-8. PubMed ID: 9231827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocorticotropin-induced hypertension in rats: role of ouabain-like compound.
    Yamada K; Goto A; Omata M
    Am J Hypertens; 1997 Apr; 10(4 Pt 1):403-8. PubMed ID: 9128206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term ouabain administration produces hypertension in rats.
    Yuan CM; Manunta P; Hamlyn JM; Chen S; Bohen E; Yeun J; Haddy FJ; Pamnani MB
    Hypertension; 1993 Aug; 22(2):178-87. PubMed ID: 8340153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of antihypertensive effect of dietary potassium in experimental volume expanded hypertension in rats.
    Pamnani MB; Chen X; Haddy FJ; Schooley JF; Mo Z
    Clin Exp Hypertens; 2000 Aug; 22(6):555-69. PubMed ID: 10972161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of ouabainlike compound in reduced renal mass-saline hypertension.
    Yamada K; Goto A; Nagoshi H; Hui C; Yagi N; Sasabe M; Omata M
    Hypertension; 1994 Jan; 23(1 Suppl):I110-3. PubMed ID: 8282341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma OLC is elevated in mild experimental uremia but is not associated with hypertension.
    Harwood S; Mullen AM; McMahon AC; Dawnay A
    Am J Hypertens; 2001 Nov; 14(11 Pt 1):1112-5. PubMed ID: 11724209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intracerebroventricular infusion of Fab fragments of digoxin antibody (Digibind) on development of reduced renal mass-saline hypertension in rats.
    Yamada K; Goto A; Hui C; Nagoshi H; Omata M
    Hypertens Res; 1995 Jun; 18(2):145-50. PubMed ID: 7584921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes in reduced renal mass rats.
    Chen S; Yuan C; Clough D; Schooley J; Haddy FJ; Pamnani MB
    Am J Hypertens; 1993 May; 6(5 Pt 1):397-406. PubMed ID: 8390268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of endogenous digitalis-like factor on hypertensive mechanisms in reduced renal mass hypertensive rats].
    Nakagawa H; Shimamoto K; Nakagawa M; Iimura O
    Nihon Naibunpi Gakkai Zasshi; 1993 May; 69(5):562-74. PubMed ID: 8330658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased myocardial Na+K+ATPase activity in rats with reduced renal mass-saline hypertension.
    Clough DL; Huot SJ; Pamnani MB; Haddy FJ
    J Hypertens; 1985 Dec; 3(6):583-9. PubMed ID: 3003189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of digoxin-specific antibody Fab fragment (Digibind) on blood pressure and renal water-sodium metabolism in 5/6 reduced renal mass hypertensive rats.
    Kaide J; Ura N; Torii T; Nakagawa M; Takada T; Shimamoto K
    Am J Hypertens; 1999 Jun; 12(6):611-9. PubMed ID: 10371371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digitalis-like factor and ouabain-like compound in plasma of volume-expanded dogs.
    Ludens JH; Clark MA; Kolbasa KP; Hamlyn JM
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S38-41. PubMed ID: 7508024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of renal natriuretic depressor systems on hypertensive mechanisms in reduced renal mass hypertensive rats.
    Shimamoto K; Ura N; Ishiguro T; Nakagawa M; Iimura O
    Hypertens Res; 1995 Jun; 18 Suppl 1():S53-7. PubMed ID: 8529075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain sodium channels and central sodium-induced increases in brain ouabain-like compound and blood pressure.
    Wang H; Leenen FH
    J Hypertens; 2003 Aug; 21(8):1519-24. PubMed ID: 12872046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Canrenone: an effective antihypertensive in an experimental model of hypertension in which the active transport of sodium is diminished].
    Grichois ML; de Mendonça M; Wauquier I; Pernollet MG; Thormann B; Devynck MA; Meyer P; Garay RP
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):875-8. PubMed ID: 3099704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypotensive action of canrenone in a model of hypertension where ouabain-like factors are present.
    De Mendonca M; Grichois ML; Pernollet MG; Thorman B; Meyer P; Devynck MA; Garay R
    J Hypertens Suppl; 1985 Dec; 3(3):S73-5. PubMed ID: 2856827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of salt loading on baroreflex sensitivity in reduced renal mass hypertension.
    Özaykan B; Taskin E; Magemizoğlu A
    Clin Exp Hypertens; 2017; 39(7):592-600. PubMed ID: 28635325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat adrenal cortex is a source of a circulating ouabainlike compound.
    Ludens JH; Clark MA; Robinson FG; DuCharme DW
    Hypertension; 1992 Jun; 19(6 Pt 2):721-4. PubMed ID: 1592473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in plasma ouabainlike inhibitor of Na+, K+-ATPase with high sodium intake in patients with essential hypertension.
    Hasegawa T; Masugi F; Ogihara T; Kumahara Y
    J Clin Hypertens; 1987 Dec; 3(4):419-29. PubMed ID: 2839625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.